ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Cesium carbonate → HCID 59519096、化合物

HRID 1161857
印刷

反応式

HRID 1161857 の反応式
C1(P(C2C=CC=CC=2)C2C=CC3C(=CC=CC=3)C=2C2C3C(=CC=CC=3)C=CC=2P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.Br[C:48]1[CH:49]=[C:50]2[C:55](=[CH:56][CH:57]=1)[N:54]=[C:53]([C:58]1[CH:63]=[CH:62][CH:61]=[C:60]([Cl:64])[CH:59]=1)[N:52]([CH2:65][C:66]([NH:68][C:69]([CH3:72])([CH3:71])[CH3:70])=[O:67])[C:51]2=[O:73].[C:74]([O:78][C:79]([N:81]1[CH2:87][CH2:86][CH2:85][NH:84][CH2:83][CH2:82]1)=[O:80])([CH3:77])([CH3:76])[CH3:75].C(=O)([O-])[O-].[Cs+].[Cs+]>C([O-])(=O)C.[Pd+2].C([O-])(=O)C.O1CCOCC1.C1(C)C=CC=CC=1>[C:74]([O:78][C:79]([N:81]1[CH2:87][CH2:86][CH2:85][N:84]([C:48]2[CH:49]=[C:50]3[C:55](=[CH:56][CH:57]=2)[N:54]=[C:53]([C:58]2[CH:63]=[CH:62][CH:61]=[C:60]([Cl:64])[CH:59]=2)[N:52]([CH2:65][C:66](=[O:67])[NH:68][C:69]([CH3:72])([CH3:71])[CH3:70])[C:51]3=[O:73])[CH2:83][CH2:82]1)=[O:80])([CH3:77])([CH3:75])[CH3:76]
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

8

反応物 4

HCID 10796Cesium carbonateHCID 634876Binap, (A+-)-HCID 2756058Tert-butyl 1,4-diazepane-1-carboxylateHCID 595190572-[6-bromo-2-(3-chlorophenyl)-4-oxo-4H-quinazolin-3-yl]-N-tert-butylacetamide

生成物 1

HCID 59519096HCID 59519096、化合物収率 46.7%

試薬・触媒・溶媒 3

HCID 167845
palladium(II) acetate
触媒
HCID 1140Toluene溶媒
HCID 312751,4-Dioxane溶媒

反応条件

温度
80 °C

実験手順

Racemic-2,2′-bis(diphenylphosphino)-1,1′-binaphthyl (5 mg, 0.009 mmol) and anhydrous toluene (0.5 mL) was heated in a microwave vial with stirring at 80° C. under an Argon atmosphere until a homogeneous milky solution was obtained (˜5 min). This solution was cooled to room temperature and palladium(II) acetate (2 mg, 0.006 mmol) was added. After stirring at room temperature for 2 min., 2-[6-bromo-2-(3-chlorophenyl)-4-oxo-4H-quinazolin-3-yl]-N-tert-butylacetamide (INTERMEDIATE VI.1) (67 mg, 0.15 mmol), tert-butyl-1-homopiperazinecarboxylate (35 μL, 0.18 mmol) and freshly ground cesium carbonate (68 mg, 0.21 mmol) were added to the red solution. Anhydrous dioxane (0.2 mL) was added to rinse down solid left on the side of the vial. The vial was capped and heated in a microwave at 120° C. for 40 min. The reaction mixture was diluted with DCM (3 mL), filtered and the filtrate concentrated in vacuo. This crude product was purified by preparative TLC on silica gel with hexane:EtOAc:CH2Cl2 (1:1:1, v/v) as eluent to give 4-[3-(tert-butylcarbamoylmethyl)-2-(3-chlorophenyl)-4-oxo-3,4-dihydroquinazolin-6-yl]perhydro-1,4-diazepine-1-carboxylic acid tert-butyl ester (INTERMEDIATE VIII.1) (38.9 mg, 0.07 mmol, 46%) as a yellow solid.

後処理

  1. customwas obtained (˜5 min)
  2. temperatureThis solution was cooled to room temperature
  3. stirringAfter stirring at room temperature for 2 min.
  4. washto rinse down solid
  5. waitleft on the side of the vial
  6. customThe vial was capped
  7. temperatureheated in a microwave at 120° C. for 40 min
  8. additionThe reaction mixture was diluted with DCM (3 mL)
  9. filtrationfiltered
  10. concentrationthe filtrate concentrated in vacuo
  11. customThis crude product was purified by preparative TLC on silica gel with hexane:EtOAc:CH2Cl2 (1:1:1

出典と根拠

ORDレコード
ord-720e0ebb9a8d44139376a7e021c74072
出典データセット
uspto-grants-2010_10
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07820649B2

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート